New function of DNA repair protein ATR discovered
Fritz Lipmann Institute (FLI) in Jena have discovered a new function of the DNA repair protein ATR in regulating ...
Zacks Investment Research on MSN12h
BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric Study
BioMarin BMRN has announced positive results from the phase III PEGASUS study evaluating Palynziq (pegvaliase) in adolescents aged 12-17 years with phenylketonuria (PKU). The study achieved its ...
FMIBlog17h
Rising Demand for Nutrition and Pharmaceuticals Fuels Amino Acids Market Growth: Reach USD 74.8 Billion by 2035
Rising Utilization in Pharmaceutical Industry The pharmaceutical sector is increasingly leveraging amino acids in drug ...
Clinical Trials Arena on MSN17h
BioMarin’s trial for phenylketonuria therapy meets primary efficacy endpoint
BioMarin Pharmaceutical has reported that the multi-centre Phase III PEGASUS trial of Palynziq (pegvaliase-pqpz) has met its ...